At Ketavita Wellness Clinic, we offer specialized IV ketamine therapy for neuropathic pain that hasn’t responded adequately to traditional treatments. When conventional medications like gabapentin, pregabalin, duloxetine, or other neuropathic pain medications haven’t provided sufficient relief from burning, shooting, or electric-shock sensations, our ketamine infusions offer a different approach through NMDA receptor antagonism that targets central sensitization and abnormal pain signal processing.
Located in Wyckoff, New Jersey, our clinic provides evidence-based care from experienced medical professionals who understand how debilitating nerve pain can be. We create personalized treatment protocols designed to help you achieve meaningful pain reduction and improved quality of life.
Every treatment journey begins with a comprehensive evaluation where we review your neuropathic pain characteristics including specific pain sensations you experience (burning, tingling, shooting, electric-like), locations and distribution of pain, severity and impact on daily activities, underlying cause if known (diabetes, injury, surgery, other), when pain began and progression patterns, previous treatments tried including medications and therapies, and how neuropathic pain affects your sleep, work, and functioning. We work closely with you throughout treatment, monitoring your response and adjusting protocols to optimize outcomes.
Neuropathic pain results from damage to or dysfunction of the nervous system itself rather than from tissue injury. This type of chronic pain affects approximately 7-10% of the population and can be particularly challenging to treat because it originates from abnormal nerve signaling rather than ongoing tissue damage that traditional pain medications target.
The hallmark of neuropathic pain is its distinctive quality. People describe sensations that differ markedly from typical pain: burning sensations often described as feeling like fire or intense heat, shooting or stabbing pain that travels along nerve pathways like electric shocks, tingling or “pins and needles” sensations, numbness combined paradoxically with pain in the same area, and extreme sensitivity to touch (allodynia) where normally non-painful stimuli like light touch or clothing cause significant pain.
These abnormal sensations reflect dysfunctional nerve signaling. Damaged or diseased nerves become hyperexcitable, generating spontaneous pain signals without external stimuli and amplifying normal sensory input into painful experiences. This creates pain that feels disproportionate to any apparent cause and often persists long after initial injury has healed.
Common causes of neuropathic pain include diabetic neuropathy affecting feet and legs from prolonged high blood sugar, post-herpetic neuralgia following shingles infection, post-surgical nerve pain from nerve damage during procedures, spinal nerve compression from herniated discs or stenosis, chemotherapy-induced peripheral neuropathy, complex regional pain syndrome following injury, traumatic nerve injuries from accidents or crush injuries, and central neuropathic pain from conditions like multiple sclerosis or stroke.
The impact extends beyond physical discomfort. Chronic neuropathic pain significantly affects sleep quality, as burning or shooting sensations often worsen at night. Many people develop depression or anxiety related to persistent pain. The unpredictable nature of pain flares creates constant worry. Activities that previously brought joy become limited or impossible. Work capacity often diminishes. Relationships suffer as pain affects mood and ability to engage socially.
Neuropathic pain involves complex changes in how the nervous system processes sensory information. Following nerve damage or disease, multiple maladaptive changes occur at peripheral nerve sites, the spinal cord, and the brain that amplify and perpetuate pain signals.
Central sensitization is a key mechanism. The central nervous system becomes hypersensitive, amplifying pain signals and perceiving pain from stimuli that wouldn’t normally be painful. This involves increased excitability of neurons in pain-processing pathways and reduced activity of pain-inhibiting systems.
Glutamate, the primary excitatory neurotransmitter, plays a critical role in central sensitization through NMDA receptors. In neuropathic pain states, excessive glutamate activity through NMDA receptors contributes to the amplification and maintenance of chronic pain. This glutamate-NMDA system undergoes “wind-up”—progressive amplification where repeated pain signals become increasingly magnified.
At the molecular level, damaged nerves show altered ion channel expression and function, making them prone to spontaneous firing and hyperexcitability. Inflammatory processes around damaged nerves contribute to ongoing sensitization. Changes in spinal cord processing alter how pain signals are transmitted to the brain. Brain regions involved in pain perception show altered activity patterns and even structural changes with chronic neuropathic pain.
Understanding these mechanisms explains why typical pain medications often fail for neuropathic pain. NSAIDs and acetaminophen target inflammation and peripheral tissue damage, which aren’t the primary drivers of neuropathic pain. Even opioids, while they affect central pain processing, are generally less effective for neuropathic pain than for nociceptive pain and carry significant risks. This drives the need for treatments specifically targeting the abnormal neural mechanisms underlying neuropathic pain.
Ketamine functions as a noncompetitive antagonist of NMDA receptors, which are centrally involved in the development and maintenance of neuropathic pain. By blocking these receptors, ketamine interrupts the excessive glutamatergic signaling that drives central sensitization and pain amplification.
The NMDA receptor antagonism produces several beneficial effects. First, ketamine directly reduces the hyperexcitability of neurons involved in pain transmission. Overactive pain pathways become less responsive, reducing spontaneous pain signals and the amplification of sensory input into painful experiences.
Second, ketamine interrupts wind-up and temporal summation—phenomena where repeated pain signals become progressively amplified. This wind-up is prominently featured in neuropathic pain states. Ketamine’s ability to block this progressive amplification provides meaningful relief from the escalating nature of nerve pain.
Third, ketamine may help reverse maladaptive neuroplastic changes that maintain chronic pain. Through increased brain-derived neurotrophic factor and synaptic remodeling, ketamine promotes beneficial neuroplasticity that could help reset dysfunctional pain-processing circuits that have developed over time.
Additionally, ketamine affects multiple other systems relevant to pain processing beyond NMDA receptors. It interacts with opioid receptors, though not as a traditional opioid. It has anti-inflammatory properties that may reduce neural inflammation contributing to pain. It enhances descending pain inhibition—the brain’s natural pain-suppressing systems. This multi-modal mechanism contributes to ketamine’s effectiveness for complex chronic pain conditions.
The onset of ketamine’s analgesic effects can be relatively rapid. While conventional neuropathic pain medications like gabapentin or duloxetine require weeks of daily use to achieve maximum benefit, ketamine research shows pain reduction can occur within hours to days following infusion. For individuals with severe neuropathic pain causing significant disability, this rapid action provides hope for relatively quick relief.
Your neuropathic pain treatment journey at Ketavita begins with a thorough evaluation. We’ll discuss your pain characteristics in detail: specific sensations you experience (burning, shooting, tingling, numbness), locations and distribution patterns, pain severity at baseline and during flares, factors that worsen or improve pain, whether pain is constant or intermittent, and how pain affects your daily activities, sleep, and quality of life.
Understanding the underlying cause is important: diabetes or other metabolic conditions, previous surgeries or injuries, infections like shingles, chemotherapy or other medications, spinal problems, or other neurological conditions. We’ll review your treatment history: all neuropathic pain medications tried (anticonvulsants, SNRIs, topicals) with their effectiveness and side effects, other interventions like nerve blocks or physical therapy, alternative approaches attempted, and current medications you’re taking.
This comprehensive assessment helps us determine if ketamine therapy is appropriate and develop an optimal treatment protocol for your specific neuropathic pain condition.
For IV ketamine therapy for neuropathic pain, treatment protocols typically involve longer infusion times than those used for mental health conditions. Chronic pain protocols often extend 2-4 hours depending on your specific needs, tolerance, and the protocol we establish. The extended infusions allow for higher cumulative doses that research suggests may be necessary for sustained pain relief in neuropathic pain conditions.
During each session, you’ll receive your ketamine infusion while resting in a private, comfortable treatment room. We monitor your vital signs continuously throughout the extended infusion. You may experience dissociative effects during treatment—feelings of detachment, altered perception, or mild euphoria—but these are temporary and typically resolve within 1-2 hours after the infusion ends.
Common side effects are generally mild and transient: temporary dissociative feelings during and shortly after infusion, dizziness or lightheadedness, mild nausea (less common but treatable), brief changes in perception or hearing, drowsiness, and temporary blood pressure elevation. These effects are short-lasting and resolve after treatment completion. The extended monitoring during longer pain infusions ensures your safety throughout.
After each treatment session, you’ll spend additional time in our office for recovery and monitoring before leaving. You cannot drive for 24 hours after ketamine treatment and must bring someone to drive you home.
Response to ketamine therapy for neuropathic pain varies among individuals. Research demonstrates that ketamine can produce significant pain reduction, with effects measurable at one week after treatment and potentially lasting up to 30 days. Meta-analyses show meaningful pain score reductions compared to placebo, though individual response varies based on neuropathic pain type, duration, and severity.
Most neuropathic pain treatment protocols involve a series of infusions rather than single treatments. Initial series typically consist of 4-8 infusions over several weeks, with maintenance sessions scheduled based on your individual response and duration of pain relief. We use standardized pain assessment tools to track your progress and adjust treatment protocols accordingly.
Ketamine therapy for neuropathic pain may be appropriate if you’ve struggled with persistent pain despite conventional treatment attempts. You may be a candidate if you’ve tried at least two different neuropathic pain medications (like gabapentin, pregabalin, duloxetine, or others) at adequate doses without sufficient relief, engaged in recommended therapies including physical therapy or other approaches without adequate benefit, found that combination treatments haven’t provided satisfactory pain control, or continue to have neuropathic pain significantly impairing your quality of life and functioning despite treatment.
Good candidates for ketamine therapy are adults with diagnosed neuropathic pain who remain significantly symptomatic despite appropriate trials of first-line treatments. Research on ketamine for neuropathic pain has included various etiologies including diabetic neuropathy, post-herpetic neuralgia, post-surgical nerve pain, complex regional pain syndrome, and other neuropathic pain conditions.
Certain factors may affect treatment suitability. During evaluation, we review cardiovascular health (ketamine temporarily raises blood pressure, particularly important with longer infusions), history of psychiatric conditions including psychosis or severe dissociative disorders, substance use history, current medications including those that might interact with ketamine, underlying cause of your neuropathic pain, and any other medical conditions affecting treatment safety. Your complete medical history helps ensure safe, appropriate treatment.
It’s important to understand that ketamine therapy for neuropathic pain represents off-label use. While systematic reviews and meta-analyses demonstrate significant pain reduction, the evidence has some limitations including variability in treatment protocols studied, relatively short-term follow-up in most studies, and clinical heterogeneity across different neuropathic pain types. We discuss current research findings transparently during consultation so you can make fully informed treatment decisions.
Our ketamine protocols for neuropathic pain are informed by substantial research demonstrating pain reduction in treatment-resistant cases. Systematic reviews and meta-analyses show that ketamine addition to standard neuropathic pain treatment produces statistically significant pain intensity reduction, with effects measurable at one week (mean difference of approximately 2 points on 0-10 pain scale) and lasting up to 30 days after treatment.
Research includes diverse neuropathic pain conditions: diabetic neuropathy, post-herpetic neuralgia, post-surgical nerve pain, complex regional pain syndrome, cancer-related neuropathic pain, and various other peripheral and central neuropathic pain states. This broad evidence base suggests ketamine may be effective across multiple neuropathic pain etiologies.
Safety is paramount in all our treatments. Ketamine has been used safely in medical settings for decades at much higher anesthetic doses, and we follow established safety protocols for subanesthetic dosing in chronic pain applications. All treatments are administered by licensed medical professionals with appropriate training, monitoring equipment, and emergency protocols. The extended infusion times required for pain treatment necessitate careful monitoring, which we provide throughout your session.
We recognize that effective neuropathic pain management requires comprehensive, multidisciplinary treatment. While ketamine can provide significant pain relief, we strongly encourage continued engagement with other evidence-based neuropathic pain interventions including appropriate medications when beneficial, physical therapy focused on functional restoration, treatment of underlying conditions when possible (like optimizing diabetes control), psychological approaches for pain coping, and other therapies appropriate for your specific condition.
Ketamine should be viewed as one component of comprehensive neuropathic pain management rather than a standalone cure. The condition often requires ongoing management across multiple domains, and optimal outcomes typically come from combining various therapeutic approaches tailored to your specific pain type and underlying cause.
Patient education is essential to our approach. We ensure you understand how ketamine works differently from conventional neuropathic pain medications, what the research shows about efficacy and duration of effects, realistic expectations given current evidence, potential side effects or risks particularly with extended infusions, and how ketamine fits into comprehensive neuropathic pain management. Informed patients with realistic expectations are better positioned to achieve optimal outcomes.
Ketamine therapy for neuropathic pain is typically not covered by insurance as it represents off-label use. We provide transparent pricing information during your consultation so you can make informed decisions about treatment.
IV ketamine therapy for neuropathic pain and other chronic pain conditions is $1,000 per session. The extended infusion protocols required for chronic pain treatment (typically 2-4 hours compared to 40 minutes for mental health conditions) necessitate this pricing, reflecting the longer treatment time, higher cumulative doses, and extended monitoring required.
A typical initial treatment series involves 4-8 infusions over several weeks, with maintenance sessions scheduled as needed based on your individual response and duration of pain relief. Research suggests some patients experience benefits lasting several weeks after treatment series, though individual response varies significantly.
The total investment depends on how many sessions you require, whether you respond favorably to treatment, and whether ongoing maintenance is necessary to sustain benefits. We’ll discuss expected treatment course and costs during your consultation based on current evidence for your specific neuropathic pain condition.
We understand that cost is a significant consideration, especially after already trying multiple treatments without success and managing ongoing neuropathic pain medication costs. However, many patients with treatment-resistant neuropathic pain find that meaningful pain reduction—decreased burning sensations, reduced shooting pains, improved sleep, restored function—significantly improves their quality of life and ability to work or engage in daily activities, potentially justifying the investment.
While insurance typically doesn’t cover ketamine therapy for neuropathic pain, we can provide receipts and clinical documentation that you may submit to your insurance company for possible out-of-network reimbursement. For an additional $50 fee, we can prepare detailed documentation for insurance submission. Coverage decisions are made by individual insurance companies based on their policies, and approval is not guaranteed.
If you’ve been struggling with neuropathic pain despite trying conventional treatments, IV ketamine therapy at Ketavita Wellness Clinic may offer new hope. Our evidence-based approach provides pain relief through NMDA receptor antagonism that targets central sensitization differently than standard neuropathic pain medications.
Schedule a consultation to discuss your neuropathic pain symptoms and their impact on your life, review your treatment history and previous responses, explore whether ketamine therapy is appropriate for your specific condition, and develop a personalized treatment protocol designed to help you achieve better pain control and improved quality of life.
Living with treatment-resistant neuropathic pain is exhausting and limiting, but you don’t have to accept persistent burning, shooting, or electric-shock sensations. Contact us today to learn how ketamine therapy can help you find the relief you’ve been seeking.
Research demonstrates significant pain reduction with ketamine treatment. Systematic reviews and meta-analyses show statistically significant pain intensity reduction at one week after treatment (approximately 2-point reduction on 0-10 pain scale) with effects lasting up to 30 days. Individual response varies based on neuropathic pain type, duration, and severity.
Research includes diverse conditions: diabetic neuropathy, post-herpetic neuralgia (shingles pain), post-surgical nerve pain, complex regional pain syndrome, chemotherapy-induced neuropathy, traumatic nerve injuries, and other peripheral and central neuropathic pain states. Evidence suggests ketamine may be effective across multiple neuropathic pain etiologies.
Duration varies among individuals. Research shows meaningful pain reduction lasting from one week up to 30 days after treatment. Some patients experience longer-lasting relief, particularly with repeated infusions and maintenance protocols. We track your individual response to determine optimal treatment intervals.
Chronic pain protocols involve significantly longer infusion times (typically 2-4 hours compared to 40 minutes for mental health conditions) and may use higher cumulative doses. The extended protocol allows for greater NMDA receptor blockade thought necessary for sustained pain relief. Pricing reflects these longer, more intensive treatment sessions.
Most protocols involve an initial series of 4-8 infusions over several weeks. Maintenance sessions may be needed to sustain benefits, with frequency determined by your individual response. Treatment plans are individualized based on your neuropathic pain type, severity, and response to initial series.
Yes, in most cases. Many patients receive ketamine therapy while continuing their existing medication regimen including anticonvulsants, SNRIs, topicals, or other neuropathic pain medications. We’ll review all your current medications during consultation to ensure there are no contraindications. Never discontinue medications without consulting your prescribing physician.
No. Ketamine is not a cure for neuropathic pain. It’s a treatment that can provide significant pain relief, potentially allowing you to engage more effectively in other therapeutic activities and improve your quality of life. Most neuropathic pain conditions are chronic and require ongoing, multidisciplinary management.
Side effects are generally mild and short-lasting, occurring during or shortly after infusion. Common effects include temporary dissociative feelings, dizziness, mild nausea, brief changes in perception, and drowsiness. These typically resolve within 1-2 hours after infusion completion. The extended infusion times for pain treatment require careful monitoring, which we provide throughout treatment.
Yes, ketamine has been studied for various chronic pain conditions including fibromyalgia, complex regional pain syndrome, and other refractory pain states. Our clinic offers ketamine therapy for multiple chronic pain conditions. The evidence base varies across different pain types.
Pain Management
Conditions Treated
365 Franklin Avenue, Wyckoff, NJ 07481